Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population-Based Prophylactic Drug Therapy for Prevention of Heart Attack

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|10|1069-1076

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.10, 2007-04, pp. : 1069-1076

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors associated with adherence to drug therapy: a population-based study

By Bardel Annika   Wallander Mari-Ann   Svärdsudd Kurt  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 307-314

Springer Publishing Company

Access to resources Recommend Favorite

Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges

By Robinson Jennifer G.  

Drugs & Aging, Vol. 26, Iss. 11, 2009-11 ,pp. : 917-931

Adis International

Access to resources Recommend Favorite

Drug therapy for prevention of cardiovascular disease — should surrogate measures be abandoned?

By Winocour Peter H  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 282-286

Royal College Of Physicians

Access to resources Recommend Favorite

Preemptive vs prophylactic therapy for CMV disease prevention

By  

Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Heart attack, stroke prevention guidelines updated by AHA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 373, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite